Brief: Astal Laboratories To Buy 100% Of Sriven Pharmachem
10/10/2025 10:39
Oct 10 (Reuters) - Astal Laboratories Ltd ASTB.BO: ASTAL LABORATORIES LTD - TO BUY 100% OF SRIVEN PHARMACHEM ASTAL LABORATORIES LTD - ACQUISITION COST SET AT 2.77 BILLION RUPEES Source text: ID:nBSE5qss1z Further company coverage: ASTB.BO ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Astal Laboratories
See all newsBrief: Astal Laboratories June-Quarter Consol Profit 94.2 Million Rupees
Brief: Astal Laboratories Signed Letter Of Intent With Immuna Therapeutics GMBH
India's Astal Laboratories gains after securing European Union export compliance
Brief: Astal Laboratories To Buy 100% Of Sriven Pharmachem
Brief: Astal Laboratories Buys Pharmaceutical Intermediates Manufacturing Plant Of Shree Venus Health Sciences